One goal of The North American Menopause Society (NAMS) is to develop position statements and other reports about clinical issues pertinent to women at midlife and beyond. Originally published in the Society's journal Menopause, these statements are available below for viewing and downloading free of charge. They are also available from NAMS in hard copy for a modest fee by using this Order Form.
Some statements provide accompanying PowerPoint slides summarizing the paper’s contents—available free of charge only to members.
2015 Nonhormonal therapy
2013 Vulvovaginal atrophy
2012 Hormone therapy
2010 Management of osteoporosis in postmenopausal women
2015 Use of compounded hormone therapy in the United States: report of The North American Menopause Society Survey 2015 NAMS Statement on Hormone Therapy Use After Age 65 2015 NAMS Editorial on use of systemic hormone therapy after age 65 2014 Algorithm and mobile app for menopausal symptom management and hormonal/non-hormonal therapy decision making: a clinical decision-support tool from The North American Menopause Society
2014 NAMS Editorial on Why the product labeling for low-dose vaginal estrogen should be changed 2014 NAMS Recommendations for Care of Midlife Women 2014 Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women’s Sexual Health and The North American Menopause Society 2013 Global Consensus Statement on Menopausal Hormone Therapy 2013 Global Consensus Statement on Menopausal Hormone Therapy—Spanish Edition 2013 Global Consensus Statement on Menopausal Hormone Therapy—French Edition 2013 Global Consensus Statement on Menopausal Hormone Therapy—Chinese Edition 2012 Kronos Early Estrogen Prevention Study (KEEPS) 2012 A Decade After The Women’s Health Initiative—The Experts Do Agree
2012 Stages of Reproductive Aging Workshop+10 2011 The role of soy isoflavones in menopausal health